iBio, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 2 of 2 Posts
Week In Review: Tasly Biopharma Completes Pre-IPO Round At $1.9 Billion Valuation
Article By: ChinaBio® Today Saturday, July 14, 2018 4:49 PM EDT
Tasly Biopharma (SHA: 600535) of Shanghai raised $84.5 million in new capital from a group of investors that included Ally Bridge. The funding is a pre-IPO round as Tasly is planning to list on the Hong Kong Exchange.
In this article: MRK, NVS, IBIO
Read
Active Stocks: Merck, OncoGenex, Ibio, OraSure, AbbVie
Article By: BioMedReports Thursday, October 16, 2014 10:58 PM EDT
AbbVie's Shire deal is dead; stocks perk up on Ebola treatment linkage
In this article: MRK, IBIO, OSUR, SHPG, OGXI, ABBV
Read
1 to 2 of 2 Posts